glp-1 and osteoporosis Losing weight on GLP-1, but have you thought about what it's doing to your bones? Research is mixed: some studies show protecting bone health, others show the opposite. The real issue GLP-1 Therapy Associated with Lower

Both peptides are synthetic and intended strictly for in vitro research, analytical purposes, or laboratory-based experimentation

Orforglipron showed stronger effects on blood sugar control, HDL cholesterol, and systolic blood pressure, while semaglutide showed larger effects on total body weight, waist circumference, and LDL cholesterol

Patients should also be seeing a registered dietitian while taking these medications

GLP-1 cardiovascular outcomes Multiple large-scale cardiovascular outcomes trials have demonstrated that GLP-1 agonists reduce the risk of major adverse cardiovascular events, including heart attack, stroke, and cardiovascular death

Its also the first to show a reduction in autoimmune disease with GLP-1 meds. Noninfectious uveitis is often associated with autoimmune disease, such as sarcoidosis, juvenile idiopathic arthritis and ankylosing spondylitis